Tnuki AI agent

Intelligence Agent

Delivers your Intelligence Brief — an executive briefing every morning on the accounts and market you care about.

Try Tnuki free Start for free. No signup, no credit card.
Intelligence Brief
Spatial Biology · US West Pharma & Biotech
847 stories, 312 LinkedIn and X posts, and 23 account deep dives analyzed
MON, APR 14
Illumina Q1 beat; single-cell revenue up 35% YoY
Apr 13 — Strong single-cell print signals rising adoption among translational teams and capacity pressure on FFPE workflows through Q2. Q1 earnings
Gilead to acquire ADC specialist Tubulis for up to $5B
Apr 14 — Validates continued ADC spend; the combined oncology portfolio reshapes the next-gen spatial-biomarker landscape. Endpoints News
Bristol-Myers × C4 Therapeutics expand protein-degrader collaboration
Apr 12 — $200M upfront doubles BMS's TPD footprint; platform buildout referenced in the latest 10-Q. BMS press
Amgen names new Chief Scientific Officer from Genentech
Apr 9 — R&D leadership transitions typically precede infrastructure reshuffles within a quarter; the Q4 call pre-announced a pipeline review. FierceBiotech
Regeneron breaks ground on $90M Tarrytown biomarker lab
Apr 10 — The new build plus VP Varma's posts on vendor demos point to a Q2 platform-evaluation window. LinkedIn
Karuna Therapeutics files 8-K with going-concern language
Apr 11 — A CFO exit last week plus a Phase 3 CYP readout due in Q2 point to a capital-raise or partnership window opening. SEC filing
Illumina Q1 beat; single-cell revenue up 35% YoY
Apr 13 — Strong single-cell print signals rising adoption among translational teams and capacity pressure on FFPE workflows through Q2. Q1 earnings
Gilead to acquire ADC specialist Tubulis for up to $5B
Apr 14 — Validates continued ADC spend; the combined oncology portfolio reshapes the next-gen spatial-biomarker landscape. Endpoints News
Bristol-Myers × C4 Therapeutics expand protein-degrader collaboration
Apr 12 — $200M upfront doubles BMS's TPD footprint; platform buildout referenced in the latest 10-Q. BMS press
Amgen names new Chief Scientific Officer from Genentech
Apr 9 — R&D leadership transitions typically precede infrastructure reshuffles within a quarter; the Q4 call pre-announced a pipeline review. FierceBiotech
Regeneron breaks ground on $90M Tarrytown biomarker lab
Apr 10 — The new build plus VP Varma's posts on vendor demos point to a Q2 platform-evaluation window. LinkedIn
Karuna Therapeutics files 8-K with going-concern language
Apr 11 — A CFO exit last week plus a Phase 3 CYP readout due in Q2 point to a capital-raise or partnership window opening. SEC filing

Why it works

Built to replace your morning scroll.

You have seven minutes before your first meeting. Tnuki Intelligence Agent does the overnight reading so you start your day with the accounts worth calling — ranked, sourced, ready.

One read, not ten tabs.

Press releases, LinkedIn, SEC filings, trade journals, X — all synthesized into one Intelligence Brief each morning. No scanning, no tabs, no FOMO.

Ranked by your market, not the world's.

Every account scored against your ICP and current target list. The #1 priority changes daily based on what actually happened overnight.

Every claim is one click from the source.

Each sentence links back to the article, filing, or post it came from. You verify before you reach out — nothing inferred, nothing generated.

In your inbox before your first meeting.

Delivered at 8 AM (or whenever you want it). No dashboard, no app to check, no notifications piling up — your brief is waiting with your coffee.

Why reps switch

The tools Tnuki replaces.

Tool Their limitation With Tnuki
Google Alerts Keyword-only, no synthesis, scattered daily emails One Intelligence Brief — consolidated, organized, and source-linked
Manual morning news scan 45+ minutes daily, easy to miss signals Delivered ready to read before coffee
ChatGPT / Perplexity briefings Hallucinates, no persistent account context Facts cited to live sources, built against your market
ZoomInfo / Apollo news feeds Cached DB, generic, no ranking Live web data, sorted by relevance to your market

Frequently asked

Common questions about Tnuki Intelligence Agent

How do I sign up for the daily brief?
Click the Daily brief button on the tnuki.com/chat home screen. Tnuki walks you through a quick guided setup — describe your market, pick a delivery time, and your Intelligence Brief starts landing in your inbox the next morning. Free to start, no credit card.
How is this different from Google Alerts?
Google Alerts pushes one email per keyword match — no synthesis, no organization, no account matching. The Intelligence Agent merges dozens of signal types into one Intelligence Brief — an executive briefing organized by what matters, with a source link on every item.
What sources does it read?
Press releases, trade journals, industry publications, LinkedIn, X, hiring boards, funding databases, and public filings. The scan runs every night across your full watchlist.
Can I customize what matters most to my market?
Yes. The agent learns from the feedback you give it during normal chat use — which signals you follow, which you ignore, which accounts matter. What surfaces adapts over time.
How do I know the insights are accurate?
Every item in the brief links to its source. Click through, read the original article, and verify before you rely on it. Tnuki's anti-hallucination validator also cross-checks every claim against source material before delivery.
Try Tnuki free No signup, no credit card. Start with one sentence.

The rest of the team

Four more agents on your pipeline.

Signal Agent

Signal-based prospecting. 1,000+ sources, 24/7, intent-grounded.

Learn more →

Contact / Waterfall Agent

Verifies emails and phones across 10+ providers.

Learn more →

Drafting Agent

Writes personalized outreach from live signal context.

Learn more →

Concierge Chat

The one chat interface behind all four agents.

Learn more →

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →